|
Market Closed -
Other stock markets
|
After hours 18:39:07 | |||
| 44.45 USD | -4.72% |
|
46.47 | +4.54% |
| 07-01 | Samsung Bioepis Relaunches BYOOVIZ® (ranibizumab-nuna) in the United States in Partnership with Harrow | CI |
| 07-01 | Harrow Announces Commercial Launch of BYOOVIZ In The United States | CI |
| Market Cap | 1.66B 1.45B 1.34B 1.23B 2.33B 160B 2.37B 16.05B 6.29B 78.18B 6.22B 6.09B 269B | P/E 2026 * |
179x | P/E 2027 * | 19.3x |
|---|---|---|---|---|---|
| Enterprise Value | 1.66B 1.45B 1.34B 1.23B 2.33B 160B 2.37B 16.05B 6.29B 78.18B 6.22B 6.09B 269B | EV / Sales 2026 * |
4.76x | EV / Sales 2027 * | 3.21x |
| Free-Float |
84.53% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Harrow, Inc.
| 1 day | -4.72% | ||
| 1 week | +6.31% | ||
| Current month | +4.66% | ||
| 1 month | +3.69% | ||
| 3 months | +9.75% | ||
| 6 months | -6.85% | ||
| Current year | -9.29% |
| 1 week | 40.85 |  | 47.5 |
| 1 month | 40.5 | | 47.5 |
| Current year | 28.54 | | 54.85 |
| 1 year | 28.54 | | 54.85 |
| 3 years | 7.6 | | 59.23 |
| 5 years | 5.4 | | 59.23 |
| 10 years | 1.35 | | 59.23 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Baum
CEO | Chief Executive Officer | 53 | 2011-12-16 |
Andrew Boll
PSD | President | 43 | 2025-08-20 |
Brett Burrell
CMP | Compliance Officer | - | 2023-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Baum
CHM | Chairman | 53 | 2021-08-18 |
Perry Sternberg
BRD | Director/Board Member | 57 | 2022-03-30 |
Adrienne Graves
BRD | Director/Board Member | 71 | 2024-01-25 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/18/26 | Free | Director | 5,248 | 0.0141% | ||
| 6/18/26 | Free | Director | 5,248 | 0.0141% | ||
| 6/18/26 | Free | Director | 5,248 | 0.0141% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.72% | +6.31% | +23.85% | +108.78% | 1.74B | |
| -2.73% | -2.96% | +48.62% | +147.27% | 1,051B | |
| -1.67% | -3.47% | +52.00% | +47.77% | 609B | |
| -0.44% | +2.17% | +33.88% | +78.20% | 450B | |
| -0.75% | +0.30% | +28.32% | +21.15% | 330B | |
| -1.52% | -1.19% | +33.38% | +35.35% | 284B | |
| -1.70% | -1.82% | +20.26% | +15.74% | 263B | |
| -0.58% | +1.11% | -20.89% | -40.59% | 223B | |
| -0.58% | +1.03% | +23.55% | +56.14% | 198B | |
| -0.80% | +1.38% | +23.09% | +66.64% | 167B | |
| Average | -1.15% | +0.84% | +26.61% | +53.65% | 357.68B | |
| Weighted average by Cap. | -0.89% | -1.07% | +35.24% | +70.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 348M 305M 282M 260M 490M 33.6B 498M 3.38B 1.32B 16.44B 1.31B 1.28B 56.64B | 516M 452M 418M 384M 725M 49.72B 737M 5B 1.96B 24.33B 1.94B 1.89B 83.82B |
| Net income | 9.81M 8.6M 7.95M 7.31M 13.79M 946M 14.01M 95.04M 37.26M 463M 36.84M 36.03M 1.59B | 92.93M 81.45M 75.29M 69.24M 131M 8.96B 133M 900M 353M 4.38B 349M 341M 15.11B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-20 | US$44.45 | -4.72% | 836,730 |
| 26-07-17 | US$46.65 | +3.94% | 827,721 |
| 26-07-16 | US$44.88 | +4.54% | 934,505 |
| 26-07-15 | US$42.93 | +3.77% | 501,135 |
| 26-07-14 | US$41.37 | -1.05% | 309,095 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HROW Stock
Select your edition
All financial news and data tailored to specific country editions
